ММВБ 3 837 0,4%  Nasdaq 14 272 0,1%  Биткойн 32 596 -3,1%  USD/RUB 72,5595 -0,1% 
РТС 1 666 1,3%  S&P500 4 242 -0,1%  Нефть 75,2 -0,3%  EUR/RUB 86,5110 -0,1% 
Dow 33 874 -0,2%  FTSE100 7 074 -0,2%  Золото 1 776 -0,2%  EUR/USD 1,1924 0,0% 

Sareum Holdings PLCShs - Профиль

Sareum Holdings Plc engages in the discovery and development of drug candidates for the treatment of cancers and autoimmune diseases. Its drug discovery pipeline includes Chk1, TYK2, and Aurora+FLT3 kinases. The company was founded by Timothy John Mitchell, David Hugh Williams, and John Charles Reader on August 1, 2003 and is headquartered in Cambridge, the United Kingdom.

Акционеры

Название Доля (%)
Freefloat96,74
Hargreaves Lansdown Stockbrokers Ltd.10,07
Hargreaves Lansdown Asset Management Ltd.6,42
HSBC Global Asset Management (UK) Ltd.4,27
First Pacific Advisors LP1,92
Thesis Asset Management Ltd.1,82
John Charles Reader, PhD1,58
Timothy John Mitchell, PhD1,54
Jarvis Investment Management Ltd.1,42
HSBC Bank Plc (Market-Maker)0,84
IG Markets Ltd.0,73

Адрес

а/я:
Телефон:
Факс:
Вэб:

Менеджмент

Добавить или редактировать инструмент